Reactivation of Multidrug-Resistant HSV-1 in a Post-Allogenic Hematopoietic Stem Cell Transplant Patient: Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing.

Autor: Zheng S; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands., Rümke LLW; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands., Tello Rubio B; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands., Rogers MRC; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands., van Sluis GL; Department of Haematology UMC Utrecht, Utrecht, The Netherlands., Kuball JHE; Department of Haematology UMC Utrecht, Utrecht, The Netherlands., Riezebos-Brilman A; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands., Lebbink RJ; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands., Verduyn Lunel FM; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 May 03; Vol. 11 (5), pp. ofae250. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial.

Autor: Rijneveld AW; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Holt B; Department of Hematology, Erasmus Medical Center Cancer Institute, Stichting Hemato-Oncologie voor Volwassenen Nederland Data Center, Rotterdam, The Netherlands., de Weerdt O; Department of Hematology, Sint Antonius Hospital, Nieuwegein, The Netherlands., Biemond BJ; Department of Hematology, Amsterdam University Medical Center, Amsterdam Medical Center, Amsterdam, The Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam, The Netherlands., van der Wagen LE; Department of Hematology, University Medical Center, Utrecht, The Netherlands., Bellido M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., van Gelder M; Department of Hematology, University Hospital Maastricht, Maastricht, The Netherlands., van der Velden WJFM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Selleslag D; St Jan Hospital, Brugge, Belgium., van Lammeren-Venema D; Department of Hematology, Haga Teaching Hospital, The Hague, The Netherlands., Halkes CJM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Fijnheer R; Department of Hematology, Meander Medical Center, Amersfoort, The Netherlands., Havelange V; St. Luc, Bruxelles, Belgium., van Sluis GL; Isala Clinic, Zwolle, The Netherlands., Legdeur MC; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Deeren D; Department of Hematology, Algemeen Ziekenhuis (General Hospital) Delta, Roeselare, Belgium., Gadisseur A; Universitair Ziekenhuis Antwerpen, Antwerp, Belgium., Sinnige HAM; Jeroen Bosch Hospital, Den Bosch, The Netherlands., Breems DA; Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerpen, Belgium., Jaspers A; Department of Hematology, CHR Citadelle, Liege, Belgium., Legrand O; Department of Hematology, Saint-Antoine Hospital, Paris, France., Terpstra WE; Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Boersma RS; Amphia Hospital, Breda, The Netherlands., Mazure D; UZ Gent, Gent, Belgium., Triffet A; Department of Hematology, Hospital André Vésale, Montigny-le-Tilleul, Belgium., Tick LW; Maxima MC, Eindhoven, The Netherlands., Beel K; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerpen, Belgium., Maertens JA; Department of Hematology, Universiteit ziekenhuis Leuven, Leuven, Belgium., Beverloo HB; Department of Cytogenetics, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands., Bakkus M; Department of Hematology, Vrije Universiteit Brussel, Brussels, Belgium., Homburg CHE; Department of Immunocytology, Sanquin Diagnostic Services, Amsterdam, The Netherlands., de Haas V; Dutch Childhood Oncology Group (SKION), Utrecht, The Netherlands; and., van der Velden VHJ; Department of Immunology, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands., Cornelissen JJ; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Blood advances [Blood Adv] 2022 Feb 22; Vol. 6 (4), pp. 1115-1125.

Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations.

Autor: Douma RA; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. r.a.douma@amc.uva.nl, van Sluis GL, Kamphuisen PW, Söhne M, Leebeek FW, Bossuyt PM, Büller HR

Publikováno v: Thrombosis and haemostasis [Thromb Haemost] 2010 Oct; Vol. 104 (4), pp. 831-6. Date of Electronic Publication: 2010 Jul 20.

The role of activated protein C in cancer progression.

Autor: van Sluis GL; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. g.l.vansluis@amc.uva.nl, Büller HR, Spek CA

Publikováno v: Thrombosis research [Thromb Res] 2010 Apr; Vol. 125 Suppl 2, pp. S138-42.

Experimental and clinical effects of anticoagulants on cancer progression.

Autor: Van Noorden CJ; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. c.j.vannoorden@amc.uva.nl, van Sluis GL, Spek CA

Publikováno v: Thrombosis research [Thromb Res] 2010 Apr; Vol. 125 Suppl 2, pp. S77-9.